Consistent with these findings, activating RAF1 fusions were recently identified in BRAF/NRAS/NF1-wild type melanomas [16], and fusions involving BRAF, RAF1, and ALK genes have been reported from a cohort of driver-negative Chinese patients with melanoma [17]. Here, ALK is linked to melanoma.